Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2006 Aug;43(8):e42.
doi: 10.1136/jmg.2005.039461.

CYP19 haplotypes increase risk for Alzheimer's disease

R Huang, S E Poduslo

CYP19 haplotypes increase risk for Alzheimer's disease

R Huang et al. J Med Genet. 2006 Aug.

Abstract

Cytochrome P450 aromatase, an enzyme that catalyses the conversion of androgens to oestrogen, is expressed at high levels in the gonads and in the brain. Aromatase activity is increased in the nucleus basalis of Meynert during aging and in Alzheimer's disease (AD), making the gene (CYP19), at 15q21.1, a potential candidate risk factor. We examined 18 single nucleotide polymorphisms spanning the 5'-untranslated region and the entire coding region of CYP19 in 227 patients with AD and 131 control spouses. We found that the gene region could be divided into two haplotype blocks; a haplotype in block 1 and a haplotype in block 2 increased the risk of developing the disease by twofold in APOE 4 carriers. The implication of two haplotypes conferring increased risk for AD warrants further investigation of the regulation of aromatase activity in brain.

PubMed Disclaimer

Conflict of interest statement

Competing interests: there are no competing interests.

References

    1. Iivonen S, Corder E, Lehtovirta M, Helisalmi S, Mannermaa A, Vepsalainen S, Hanninen T, Soininen H, Hiltunen M. Polymorphisms in the CYP19 gene confer increased risk for Alzheimer disease. Neurology 2004621170–1176. - PubMed
    1. Bulun S E, Sebastian S, Takayama K, Suzuki T, Sasano H, Shozu M. The human CYP19 (aromatase P450) gene: Update on physiologic roles and genomic organization of promoters. J Steroid Biochem and Mol Biol 200386219–224. - PubMed
    1. Ishunina T A, van Beurden D, van der Meulen, Unmehopa U A, Hol E M, Huitinga I, Swaab D F. Diminished aromatase immunoreactivity in the hypothalamus, but not in the basal forebrain nuclei in Alzheimer's disease. Neurobiol Aging 200526173–194. - PubMed
    1. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan E. Clinical diagnoses of Alzheimer's disease: Report of the NINCDS‐ADRDA work group under the auspices of Department of Health and Human Services task force on Alzheimer's disease. Neurology 198434939–944. - PubMed
    1. Gabriel S B, Schaffner S F, Nguyen H, Moore J M, Roy J, Blumenstiel B, Higgins J, DeFelice M, Lochner A, Faggart M, Liu‐Cordero S N, Rotimi C, Adeyemo A, Cooper R, Ward R, Lander E S, Daly M J, David Altshuler D. The structure of haplotype blocks in the human genome. Science 20022962225–2229. - PubMed

Publication types